REST protects dopaminergic neurons from mitochondrial and α-synuclein oligomer pathology in an alpha synuclein overexpressing BAC-transgenic mouse model
Alpha-synuclein pathology is associated with dopaminergic neuronal loss in the substantia nigra (SN) of Parkinson's patients. Working across human and mouse models, we investigated mechanisms by which the accumulation of soluble α-synuclein oligomers leads to neurodegeneration. Bioche...
Main Authors: | Ryan, BJ, Bengoa-Vergniory, N, Williamson, M, Kirkiz, E, Roberts, R, Corda, G, Sloan, M, Saqlain, S, Cherubini, M, Poppinga, J, Bogtofte, H, Cioroch, M, Hester, S, Wade-Martins, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Society for Neuroscience
2021
|
Similar Items
-
Alpha-synuclein oligomers: a new hope.
by: Bengoa-Vergniory, N, et al.
Published: (2017) -
Alpha-synuclein proximity ligation assay (AS-PLA) in brain sections to probe for alpha-synuclein oligomers
by: Roberts, RF, et al.
Published: (2019) -
Targeting alpha-synuclein as a therapy for Parkinson’s disease
by: Fields, CR, et al.
Published: (2019) -
Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P α-synuclein BAC transgenic mouse.
by: Taylor, T, et al.
Published: (2014) -
Loss of microRNA-7 regulation leads to α-synuclein accumulation and dopaminergic neuronal loss in vivo
by: McMillan, K, et al.
Published: (2017)